Related Experiment Video
Updated: Feb 20, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
The AMPK activator A769662 promotes ferroptosis and suppresses disulfidptosis by inhibiting SLC7A11
Una Misono1, Nanoka Ishida2, Ayane Fumuro3
1Department of Biological Chemistry, Graduate School of Science, Osaka Metropolitan University, Gakuen-cho, Naka-ku, Sakai, Osaka, 599-8531, Japan.
Abstract:
AMP-activated protein kinase (AMPK) plays a critical role in maintaining cellular energy homeostasis. Activation of AMPK negatively regulates ferroptosis, a form of cell death caused by iron-dependent accumulation of lipid peroxides. In the present study, we unexpectedly found that A769662, widely used as a selective AMPK activator, inhibited SLC7A11-mediated cystine uptake, thereby decreasing intracellular reduced glutathione (GSH) levels and promoting ferroptosis in glioblastoma cells. Deletion of the AMPKα1 gene or treatment with an AMPK inhibitor compound C did not inhibit A769662-induced promotion of ferroptosis. In addition, A769662 suppressed disulfidptosis, a recently identified form of cell death caused by SLC7A11-mediated cystine uptake under glucose deprivation. On the other hand, AICAR, another AMPK activator, had no effect on cystine uptake and intracellular GSH levels. These results suggest that A769662 inhibits SLC7A11-mediated cystine uptake to promote ferroptosis and suppress disulfidptosis in an AMPK-independent manner.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
ATP Synthase: Mechanism
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...